Gregory Bociek
Overview
Explore the profile of Gregory Bociek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Kadhimi Z, Pirruccello S, Gul Z, Maness-Harris L, Bhatt V, Gundabolu K, et al.
Bone Marrow Transplant
. 2022 Aug;
57(10):1629-1631.
PMID: 35953707
No abstract available.
2.
Armitage J, Montero C, Benner A, Armitage J, Bociek G
Clin Lymphoma Myeloma
. 2008 Sep;
8(4):253-5.
PMID: 18765315
The aim of this study was to describe the occurrence of acute coronary syndromes in 3 cases of rituximab infusions. We reviewed the records of 3 patients with lymphoproliferative disorders...
3.
Vose J, Bierman P, Enke C, Hankins J, Bociek G, Lynch J, et al.
J Clin Oncol
. 2004 Nov;
23(3):461-7.
PMID: 15534357
Purpose: To determine the maximum outpatient dose of iodine-131 tositumomab (up to 0.75 Gy) combined with high-dose carmustine, etoposide, cytarabine, and melphalan (BEAM) followed by autologous stem-cell transplantation (ASCT) for...
4.
Giles F, Vose J, Do K, Johnson M, Manshouri T, Bociek G, et al.
Leuk Res
. 2004 May;
28(6):595-604.
PMID: 15120936
Vascular endothelial growth factor (VEGF), basic-fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), and angiogenin are important angiogenic factors. In 65 patients with non-Hodgkin's lymphoma (NHL), pre-treatment VEGF, bFGF, and...
5.
Giles F, Vose J, Do K, Johnson M, Manshouri T, Bociek G, et al.
Br J Haematol
. 2003 Nov;
123(5):850-7.
PMID: 14632776
The cell surface proteins CD20 and CD52 differ significantly in their structures and are expressed on the majority of B cells. Both circulating CD20 (cCD20) and circulating CD52 (cCD52) have...
6.
Vose J, Weisenburger D, Lynch J, Bierman P, Chan J, Bast M, et al.
Leuk Lymphoma
. 2002 Aug;
43(4):799-804.
PMID: 12153167
The purpose of this study was to evaluate the CNOP regimen (cyclophosphamide, mitoxantrone, vincristine, and prednisone) throughout a community based oncology network with a large number of elderly non-Hodgkin's lymphoma...
7.
Weekes C, Vose J, Lynch J, Weisenburger D, Bierman P, Greiner T, et al.
J Clin Oncol
. 2002 Feb;
20(4):1087-93.
PMID: 11844834
Purpose: Hodgkin's disease (HD) is a malignancy that displays a bimodal age distribution. Previous reports of treatment in patients greater-than-or-equal 60 years have found a poor outcome, particularly in patients...